• OPEN AN ACCOUNT
Indian Indices
Sensex
74,828.25 299.17
( 0.40%)
Global Indices
Nasdaq
51,895.24 -174.59
(-0.34%)
Dow Jones
7,786.35 0.65
(0.01%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,716.75 8.42
(0.08%)
Forex
USD-INR
95.81 -0.17
(-0.18%)
EUR-INR
109.93 -0.31
(-0.28%)
GBP-INR
128.18 -0.37
(-0.29%)
JPY-INR
0.61 0.00
(-0.38%)

EQUITY - MARKET SCREENER

Indo US Bio-Tech Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
541304
INE250Z01010
46.1460203
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
INDOUS
13.83
158.39
EPS(TTM)
Face Value()
Div & Yield %
5.71
10
0
 

Procter & Gamble Health standalone net profit rises 54.63% in the March 2026 quarter
May 27,2026
Net profit of Procter & Gamble Health rose 54.63% to Rs 94.60 crore in the quarter ended March 2026 as against Rs 61.18 crore during the previous quarter ended March 2025. Sales rose 19.12% to Rs 370.45 crore in the quarter ended March 2026 as against Rs 310.99 crore during the previous quarter ended March 2025.

For the full year,net profit rose 39.46% to Rs 326.91 crore in the year ended March 2026 as against Rs 234.41 crore during the previous year ended March 2025. Sales rose 50.72% to Rs 1407.97 crore in the year ended March 2026 as against Rs 934.17 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales370.45310.99 19 1407.97934.17 51
OPM %36.6026.02 -32.4334.08 -
PBDT139.3883.90 66 473.45328.31 44
PBT133.2178.53 70 449.86311.62 44
NP94.6061.18 55 326.91234.41 39